(2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one

C53H85FI2N6O13 — CID 89372162

IUPAC(2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one
SMILESCO[C@H](c1ccc(-c2ccc(=O)[nH]c2)cc1)[C@@H](CF)N(N)/C=C(/CCN(C)[C@@H]1C[C@H](O[C@@H]2C[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](I)[C@@](C)(O)[C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@]2(C)O)O[C@H](C)C1)NI
InChIInChI=1S/C53H85FI2N6O13/c1-30-24-51(6,67)42(23-41(73-45-25-52(7,70-12)48(65)34(5)72-45)32(3)49(66)75-50(55)53(8,68)47(64)33(4)61(10)28-30)74-44-22-39(21-31(2)71-44)60(9)20-19-38(59-56)29-62(57)40(26-54)46(69-11)36-15-13-35(14-16-36)37-17-18-43(63)58-27-37/h13-18,27,29-34,39-42,44-48,50,59,64-65,67-68H,19-26,28,57H2,1-12H3,(H,58,63)/b38-29-/t30-,31-,32-,33-,34+,39+,40-,41+,42-,44+,45+,46-,47-,48+,50+,51-,52-,53+/m1/s1
InChIKeyLSELCYLTYMKCGU-LCKURIJVSA-N
MW1287.10 g/mol
LogP5.46
Rot. Bonds17

About (2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one

(2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one (PubChem CID 89372162) has the molecular formula C53H85FI2N6O13 and a molecular weight of 1287.10 g/mol. Its IUPAC name is (2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one.

Molecular Properties

Compound Name(2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one
PubChem CID89372162
Molecular FormulaC53H85FI2N6O13
Molecular Weight1287.10 g/mol
Exact Mass1286.42
IUPAC Name(2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one
SMILESCO[C@H](c1ccc(-c2ccc(=O)[nH]c2)cc1)[C@@H](CF)N(N)/C=C(/CCN(C)[C@@H]1C[C@H](O[C@@H]2C[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](I)[C@@](C)(O)[C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@]2(C)O)O[C@H](C)C1)NI
InChIInChI=1S/C53H85FI2N6O13/c1-30-24-51(6,67)42(23-41(73-45-25-52(7,70-12)48(65)34(5)72-45)32(3)49(66)75-50(55)53(8,68)47(64)33(4)61(10)28-30)74-44-22-39(21-31(2)71-44)60(9)20-19-38(59-56)29-62(57)40(26-54)46(69-11)36-15-13-35(14-16-36)37-17-18-43(63)58-27-37/h13-18,27,29-34,39-42,44-48,50,59,64-65,67-68H,19-26,28,57H2,1-12H3,(H,58,63)/b38-29-/t30-,31-,32-,33-,34+,39+,40-,41+,42-,44+,45+,46-,47-,48+,50+,51-,52-,53+/m1/s1
InChIKeyLSELCYLTYMKCGU-LCKURIJVSA-N
XLogP5.46
TPSA243.23 Ų
H-Bond Donors7
H-Bond Acceptors18
Rotatable Bonds17
Heavy Atoms75
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001287.10
LogP ≤ 55.46
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}, {'alert_name': 'N-halo', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(2R,3S,4S,7R,9R,10R,11S,12S,13R)-10-[(2S,4S,6R)-4-[2-[1-[(1R,2S)-1-[4-(3,3-difluoropyrrolidin-1-yl)phenyl]-3-fluoro-1-methoxypropan-2-yl]triazol-4-yl]ethyl-methylamino]-6-methyloxan-2-yl]oxy-3,4,9-trihydroxy-12-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,7,9,11,13-hexamethyl-1-oxa-5-azacyclotetradecan-14-one
CID 89372201
4-[(1R,2S)-3-fluoro-1-methoxy-2-[4-[2-[methyl-[(2R,4S,6S)-2-methyl-6-[[(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-3,4,10-trihydroxy-13-[(4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]-2-iodo-3,5,6,8,10,12,14-heptamethyl-15-oxo-1-oxa-6-azacyclopentadec-11-yl]oxy]oxan-4-yl]amino]ethyl]triazol-1-yl]propyl]benzaldehyde
CID 89372138
(2R,3S,4R,5R,8R,10S,13S,14R)-10-[1-[1-[4-[(1R,2S)-3-fluoro-2-[4-[2-[[(2R,4S,6R)-2-hydroxy-6-methyloxan-4-yl]-methylamino]ethyl]triazol-1-yl]-1-methoxypropyl]phenyl]triazol-4-yl]butoxy]-3,4-dihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one
CID 89371745
N-[4-[(1R,2S)-2-[amino-[(Z)-4-[[(2S,4S,6R)-2-[[(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-[(2S,4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-1-oxa-6-azacyclopentadec-11-yl]oxy]-6-methyloxan-4-yl]-methylamino]-2-(methylideneamino)but-1-enyl]amino]-3-fluoro-1-methoxypropyl]phenyl]-2-chloroacetamide
CID 129313143
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-11-[(2S,4S,6R)-4-[2-[1-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(1-methylpyrazol-4-yl)phenyl]propan-2-yl]triazol-4-yl]ethyl-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
CID 134395539
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-11-[(2S,4S,6R)-4-[2-[1-[(1R,2S)-3-fluoro-1-methoxy-1-(4-pyridin-3-ylphenyl)propan-2-yl]triazol-4-yl]ethyl-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
CID 134395475
(2R,3S,4R,5R,8R,10R,11R,13S,14R)-2-ethyl-11-[(2S,4S,6R)-4-[2-[1-[(1R,2S)-3-fluoro-1-[4-[(3S)-3-fluoropyrrolidin-1-yl]phenyl]-1-methoxypropan-2-yl]triazol-4-yl]ethyl-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,14-pentamethyl-1-oxa-6-azacyclopentadecan-15-one
CID 89372021
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-[[(Z)-3-amino-4-[amino-[(1R,2S)-1-[4-[(1R,5S)-6-(benzhydrylideneamino)-3-azabicyclo[3.1.0]hexan-3-yl]phenyl]-3-fluoro-1-methoxypropan-2-yl]amino]but-3-enyl]-methylamino]-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
CID 129313557
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-11-[(2S,4S,6R)-4-[2-[1-[(1R,2S)-3-fluoro-1-methoxy-1-(4-propan-2-ylsulfonylphenyl)propan-2-yl]triazol-4-yl]ethyl-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
CID 134395358
(2R,3S,4R,5R,8R,10R,11R,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,14-hexamethyl-11-[[(1R,2S,4R,6R)-4-methyl-3-oxabicyclo[4.1.0]heptan-2-yl]oxy]-1-oxa-6-azacyclopentadecan-15-one
CID 142276198
(2R,3S,4R,5R,8R,10R,11R,13S,14R)-2-ethyl-11-[(2S,4S,6R)-4-[2-[1-[(2S)-1-fluoro-3-[4-(1-methylpyrazol-4-yl)phenyl]propan-2-yl]triazol-4-yl]ethyl-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,14-pentamethyl-1-oxa-6-azacyclopentadecan-15-one
CID 89372217
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-11-[(2S,4S,6R)-4-[2-[1-[(1R,2S)-3-fluoro-1-[4-[(3S)-3-fluoropyrrolidin-1-yl]phenyl]-1-methoxypropan-2-yl]triazol-4-yl]ethyl-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
CID 134395533

Frequently Asked Questions

What is the IUPAC name of (2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one?
The IUPAC name of (2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one (CID 89372162) is (2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one.
What is the SMILES notation for (2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one?
The canonical SMILES for (2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one is CO[C@H](c1ccc(-c2ccc(=O)[nH]c2)cc1)[C@@H](CF)N(N)/C=C(/CCN(C)[C@@H]1C[C@H](O[C@@H]2C[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](I)[C@@](C)(O)[C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@]2(C)O)O[C@H](C)C1)NI.
What is the InChIKey of (2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one?
The InChIKey is LSELCYLTYMKCGU-LCKURIJVSA-N. The full InChI is InChI=1S/C53H85FI2N6O13/c1-30-24-51(6,67)42(23-41(73-45-25-52(7,70-12)48(65)34(5)72-45)32(3)49(66)75-50(55)53(8,68)47(64)33(4)61(10)28-30)74-44-22-39(21-31(2)71-44)60(9)20-19-38(59-56)29-62(57)40(26-54)46(69-11)36-15-13-35(14-16-36)37-17-18-43(63)58-27-37/h13-18,27,29-34,39-42,44-48,50,59,64-65,67-68H,19-26,28,57H2,1-12H3,(H,58,63)/b38-29-/t30-,31-,32-,33-,34+,39+,40-,41+,42-,44+,45+,46-,47-,48+,50+,51-,52-,53+/m1/s1.
What are the key properties of (2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one?
(2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one has a molecular weight of 1287.10 g/mol, XLogP of 5.46, 17 rotatable bonds, 7 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,4S,6R)-4-[[(Z)-4-[amino-[(1R,2S)-3-fluoro-1-methoxy-1-[4-(6-oxo-1H-pyridin-3-yl)phenyl]propan-2-yl]amino]-3-(iodoamino)but-3-enyl]-methylamino]-6-methyloxan-2-yl]oxy-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2-iodo-3,5,6,8,10,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one is sourced from PubChem (CID 89372162), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).